OTC · Drug Manufacturers - Specialty & Generic

Hemp, Inc (HEMP) Stock

$0.00 OTC: HEMP Healthcare

Hemp, Inc. operates primarily within the industrial hemp sector.

Valuation

MetricValue
Price$0.00
Market Cap$882950
P/E Ratio-0.25
P/B Ratio0.05
P/S Ratio6.44
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.72%
ROA-4.62%
ROCE-7.51%
Gross Margin47.64%
Operating Margin-2554.43%
Net Margin0.00%
Debt/Equity2.34
Current Ratio51.48

Annual Financials (USD)

Metric20182019202020212022
Revenue$2.0M$2.0M$3.0M$0$0
Operating Profit$-14.0M$-10.0M$-5.0M$-14.0M$-3.0M
Net Profit$-39.0M$-27.0M$-13.0M$-25.0M$-5.0M
EPS$-0.01$-0.01$0.00$0.00$0.00
Op Margin-722.3%-407.8%-211.3%-32476.4%-1793.1%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$21.0M$43.0M$45.0M$45.0M$44.0M
Total Liabilities$15.0M$23.0M$27.0M$30.0M$31.0M
Cash$0$0$0$0$0
Borrowings$14.0M$23.0M$26.0M$29.0M$31.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-10.0M$-15.0M$-12.0M$-15.0M$0
Investing Cash Flow$-8.0M$-20.0M$0$0$1.0M
Financing Cash Flow$11.0M$15.0M$6.0M$12.0M$4.0M
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-14.0M$-24.0M$-12.0M$-15.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA164.42
FCF Yield-0.57%
Quick Ratio36.29
Interest Coverage-1.40
Return 1Y0.00%
Return 3Y-75.00%
Return 5Y

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Motiv8 Investments LLC 1,0002025-12-31
Pinnacle Wealth Management Advisory Group, LLC25,0002026-03-31
Diversified Trust Company50,0002026-06-30
NVWM, LLC1002026-06-30
Ascentis Wealth Management, LLC5,0002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANTCFAion Therapeutic Inc. $0.00 $2.07M 0.00%
BHNGFBhang Inc. $0.00 -0.01 $19965 0.00%
EVIOEVIO, Inc. $0.00 1.67 $959685 0.00%
FWDGFutureWorld Corp. $0.00 -0.10 $263644 0.00%
IGEXIndo Global Exchange(s) PTE, Ltd. $0.00 -20.47 $2.24M 0.00%

About Hemp, Inc

Hemp, Inc. operates primarily within the industrial hemp sector. Its diverse product range includes various hemp-derived offerings, such as their "King of Hemp" pre-roll blends, fortified pre-rolls, Bubba Kush hemp flower, specialized caviar/moon rocks, and concentrated diamonds and crumbles. Beyond retail products, the company is actively involved in the cultivation and processing of industrial hemp, alongside the extraction of CBD oil. It also plays a crucial role in empowering and educating hemp farmers and entrepreneurs, supplying them with vital knowledge, processing capabilities, infrastructure, and general support. Furthermore, Hemp, Inc. offers a wide array of hemp-related accessories and equipment for sale, encompassing extractors, harvesters, storage solutions, various containers, fertilizers, soil amendments, humidity control devices (humidifiers and dehumidifiers), balers, and comprehensive greenhouse systems. The firm extends its services to other hemp cultivators, providing post-harvest activities such as drying, trimming, curing, storing, and brokering harvested hemp. Complementing these activities, it also conducts research and development, offers professional hemp consulting, and delivers engaging educational entertainment. Established in 2008, the company initially operated as Marijuana, Inc. before officially rebranding to Hemp, Inc. in June 2012. Its corporate headquarters are located in Las Vegas, Nevada.

Hemp, Inc (HEMP) stock trades at $0.00 with a market capitalization of $882950. The stock is valued at a price-to-earnings (P/E) ratio of -0.25, price-to-book of 0.05, price-to-sales of 6.44. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Hemp, Inc generates a return on equity (ROE) of -38.72%, return on capital employed of -7.51%, an operating margin of -2554.43%, a net profit margin of 0.00%.

Official website: www.hempinc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides